Elgen Therapeutics is a South Korean biotechnology startup developing oncology drugs, focusing on anticancer therapeutics that degrade disease-causing target proteins using targeted protein degradation (TPD) and PROTAC technology
Elgen Therapeutics is a South Korean biotechnology startup developing oncology drugs, focusing on anticancer therapeutics that degrade disease-causing target proteins using targeted protein degradation (TPD) and PROTAC technology.